Coding and noncoding GATA2 mutations cause GATA2-deficiency syndromes, which often involve immunodeficiency and predisposition to develop myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) (15, 44, –, 48). Here, GATA2 is linked to immune system disorder.